Board of Trustees


Dr. Dennis is Distinguished Professor of Chemistry, Biochemistry and Pharmacology in the School of Medicine at the University of California at San Diego (UCSD). He received his BA from Yale University and Ph.D. from Harvard University, Doctorates in Medicine (honorary) from Goethe University in Frankfurt and the University of Lyon-INSA, and was a Research Fellow at Harvard Medical School. At UCSD, he has served as Chair of the Department of Chemistry and Biochemistry, as Chair of the Faculty Academic Senate, and on the Board of Overseers. Dr. Dennis’ career research focus has been on the mechanism of the enzyme phospholipase A2, signal transduction, inflammation, lipid metabolism, oxidized lipids, eicosanoids, and developing the lipidomics field. He has authored over 380 research publications and books and numerous patents. He is currently Editor-in- Chief of the Journal of Lipid Research and Director of the LIPID MAPS Consortium. He is an inaugural Fellow of the AAAS and received the ASBMB Avanti Award in Lipid Enzymology, the European Federation for Lipid Science and Technology’s European Lipid Science Award, and Yale University’s Yale Medal. He served on the Yale University Council and the Boards of Trustees of the Keystone Symposia, which he chaired from 1996-2004, the Gordon Research Conferences, which he chaired, the American Society for Biochemistry and Molecular Biology, and the La Jolla Playhouse.

Peter C. Farrell, PhD, DSc

Dr. Peter Farrell is Founder, former long-term CEO and Chairman of ResMed, Inc. (RMD). He was formerly an academic at the University of New South Wales, Sydney and prior to that the University of Washington, Seattle. Before founding ResMed Peter was Vice President of R&D for Baxter, Japan and founded the Baxter Center for Medical Research in Sydney. He was named E&Y San Diego Entrepreneur of the Year for Health Sciences in 1998 and E&Y Australian Entrepreneur of the Year in 2001. Dr. Farrell was admitted to the Order of Australia in 2004 and in 2005 was named E&Y United States Entrepreneur of the Year in Health Sciences. In 2012, Farrell was admitted to the U.S. National Academy of Engineering and in 2016 he was awarded the Chancellor’s Medal by the University of California San Diego. Dr. Farrell was also the Chair of the Executive Council of Harvard Medical School’s Division of Sleep Medicine (2011-13) and is on the Visiting Committee of the Harvard/MIT Institute for Medical Engineering and Science (IMES). He holds degrees in chemical and/or biomedical engineering from the University of Sydney, the Massachusetts Institute of Technology, the University of Washington, Seattle and the University of New South Wales and is the author of over 150 peer-reviewed research publications or books.

Mary Berglund,PhD

Mary Berglund, Ph.D., is the Executive Vice President of the J. Berglund Company, Inc., a private asset and portfolio management company located in La Jolla since 1984. She is a former academic economist who has specialized in the economic impacts of government regulation. She was a consultant for the Federal Railroad Administration, the U.S. Department of Transportation and the Association of American Railroads. She received her M.A. and Ph.D. degrees in Economics from the University of Nebraska where she was an assistant professor; she then was a Research Associate at the University of California Irvine, Institute of Transportation Studies. She also has been a lecturer at the University of San Diego and in the Urban Studies Program at the University of California San Diego. During the 1990s she was a Commissioner and past Chairman of the California Transportation Commission (CTC) that funds the State’s transportation infrastructure. As a long-time San Diego resident, Mary has been involved in many non-profits in the community and has served on a number of investment committees. She currently is a Director and Treasurer of the Charles Lee Powell Foundation and a Trustee and past president of the Museum of Contemporary Art, San Diego.

Charles G. Cochrane, MD

Dr. Cochrane is Professor Emeritus of The Scripps Research Institute (TSRI), was one of the 5 Founders of TSRI in 1961 and Adjunct Professor of Pathology at the University of California, San Diego. He is author of over 320 peer-reviewed scientific articles dealing with the molecular and cellular mechanisms of immunologic and inflammatory states. He invented the synthetic peptide pulmonary surfactant, KL4-Surfactant, which is given to preterm infants to expand their lungs and save lives. The KL4-Surfactant is undergoing tests in other diseases currently. He received 40 national and international awards together with lectureships such as the Klemperer Award of the NY Academy of Medicine (1995), the “Frontiers of Medicine” lectureship of the Nobel Symposium in Stockholm, Sweden (1999), the American Lung Association “Live and Breathe Award (2004), the Ravdin Lecture of the American College of Surgeons (1983), the Centennial Speaker of the National Institutes of Health (1986) and at the “Molecular Basis of Inflammation” in Heidelberg, Germany (1993). He has served on 11 Editorial Boards of international scientific journals and consultantships for 10 organizations or companies including the Arthritis Foundation, the American Heart Association, the National Multiple Sclerosis Society, the American Cancer Society and as a member of the Board of Scientific Advisors for Merck Sharp and Dohme. Dr. Cochrane is also a member and past-President of the Board of Trustees of the Museum of Contemporary Art San Diego.

Michael P. Coppola, MD

Michael P. Coppola, MD FACP received his medical training at Georgetown University School of Medicine and is currently Executive Vice President of Medical Affairs and Chief Medical Officer of NovaSom, Glen Burnie, MD, a national home sleep testing company. Dr. Coppola has been a longtime advocate for home sleep testing, having published the first case series of patients diagnosed in the ambulatory setting in 1993. He has been a national voice for improving recognition and access to care for patients with sleep apnea and has been active in a number of national and international organizations. He previously served as President and Chief Medical Officer of the American Sleep Apnea Association, the only patient advocacy organization for patients with sleep disordered breathing. He is board certified in Internal Medicine, Pulmonary, Critical Care and Sleep Medicine. Until recently he practiced Sleep and Pulmonary Medicine in Springfield Massachusetts, where he was CEO of a multi-specialty medical practice, a certified NCQA level III Patient Centered Medical Home, Medical Director of the sleep program at Mercy Medical Center and on the faculty at Baystate Medical Center (Tufts U. School of Medicine) where he was Associate Clinical Professor of Medicine. He was on the Board of Directors of the Baystate PHO and the Board of Health New England a 100,000 member HMO. He has received numerous awards and honors and had been listed in America’s Best Doctors for years.

Anthony DeMaria, MD

Anthony N. DeMaria received his M.D. from the New Jersey College of Medicine in 1968. He did his medical residency at the United States Public Health Service Hospital in Staten Island, New York. He completed his cardiology fellowship training at the University of California, Davis and upon completion joined the faculty at UC Davis. In 1981, he accepted the position as Chief of Cardiology at the University of Kentucky in Lexington, Kentucky. He remained in that position until 1992 when he accepted the position as Professor of Medicine and Chief, Division of Cardiology at the University of California, San Diego. In 2004 he founded the UCSD Sulpizio Family Cardiovascular Center. His field of specialization is cardiac imaging techniques, particularly echocardiography (ultrasound of the heart). Dr. DeMaria is a Diplomat in the American Board of Internal Medicine and is board certified by the Subspecialty Board in Cardiovascular Disease. He is Past President of the American College of Cardiology and Past President of the American Society of Echocardiography. He has served as a member of the Subspecialty Board on Cardiovascular Disease of the American Board of Internal Medicine and Chair of the Diagnostic Radiology Study Section of the National Institutes of Health. He holds memberships in numerous professional organizations, including the American Heart Association, the American Federation for Clinical Research and the Association of University Cardiologists.

Dr. DeMaria is currently the Editor-in-Chief of the Journal of the American College of Cardiology and has served as an editorial consultant and member of various other editorial boards. He has authored or co-authored over 530 articles for medical journals. Dr. DeMaria is listed in the Best Doctors in America and by Good Housekeeping as Best Heart Doctors in America.


Sir Neil Douglas was until 2012 Professor of Respiratory & Sleep Medicine at the University of Edinburgh and an Honorary Consultant Physician at the Royal Infirmary of Edinburgh. He has published extensively on the causation, consequences and treatment of sleep apnoea. Previous roles included President of the British Sleep Society, Secretary of the British Thoracic Society, President of the Royal College of Physicians of Edinburgh and Chairman of the UK Academy of Medical Royal Colleges. He is Chairman of the UK Faculty of Medical Leadership and Management.

Carlos Nunez, MD

As Chief Medical Officer for ResMed, Dr. Nunez leads Medical Affairs, Market Access, Healthcare Economics, Government Affairs, Clinical Safety and Compliance and Clinical Science and Innovation. This global, multidisciplinary team provides the professional and scientific expertise to align the clinical, economic and public policy realities of modern healthcare with the patient-centered mission and business strategy of ResMed. This includes the clinical aspects of safety, quality and regulatory efforts that touch every phase of the patient experience and product lifecycle, as well as the evidence generation, early-stage technology development and advanced data analytics, including machine learning (ML) and artificial intelligence (AI), that defines the cutting edge of clinical research and medical science in sleep and respiratory care.

Carlos joined ResMed from Becton, Dickinson and Company where he was Senior Vice President of Medical Affairs. Prior to that, Carlos was Chief Medical Officer at CareFusion, where he built and led a global team that provided medical oversight for all businesses and functions of the company. Carlos received his Medical Doctor degree from the University of Miami School of Medicine; where he also completed postgraduate training in anesthesiology, critical care medicine and clinical research. Before beginning his career in the MedTech industry, Carlos was a practicing anesthesiologist, intensivist and hospitalist, as well as director of critical care research, informatics and analytics.

Klaus Schindhelm, BE, PhD

Dr. Schindhelm is Senior Vice President, Global Applied Research, ResMed Ltd, having joined ResMed in 1998. From January 1995 to June 1998, Dr. Schindhelm was Professor and Head, Graduate School of Biomedical Engineering, the University of New South Wales. He continues to hold a Chair in Biomedical Engineering at the University of New South Wales. He has broad experience in medical device technologies in general and in respiratory and sleep technologies in particular. He was the Founding Chairman of the College of Biomedical Engineers, the Institution of Engineers, Australia and a Founding Fellow of the International Academy for Medical and Biological Engineering. He currently chairs the Vision Cooperative Research Centre and the Therapeutic Goods Committee for the Therapeutic Goods Administration, Australia.

Jonathan R. L. Schwartz, MD

Dr. Jonathan Schwartz is a Clinical Professor of Medicine at the University of Oklahoma Health Sciences Center and is the medical director of the Integris Sleep Disorders Center in Oklahoma City. He is a graduate of Oklahoma University Medical School and Health Sciences Center, where he also completed an internship and residency in internal medicine and a fellowship in pulmonary disease and critical care medicine. He is board certified in sleep disorders medicine, internal medicine and pulmonary medicine. He has served as a principal investigator in numerous research projects involving obstructive sleep apnea, insomnia, narcolepsy, shift work sleep disorder and restless leg syndrome. He has authored a number of articles and chapters regarding the diagnosis and treatment of sleep and breathing disorders. He serves as the volunteer medical director of the Baptist Community Care Inner City Clinic in Oklahoma City. He has received numerous honors and awards and has been named to Best Doctors in America since 2001.